Know Cancer

or
forgot password

Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery


N/A
18 Years
75 Years
Not Enrolling
Both
Basal Cell Carcinoma, Squamous Cell Carcinoma

Thank you

Trial Information

Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery

Inclusion Criteria


Inclusion Criteria

- Age: 18-75

- Basal cell carcinoma or squamous cell carcinoma of the head or neck

- Subjects are in good health

- Subjects that have the willingness and the ability to understand and provide informed
consent for the use of their blood and communicate with the investigator

Exclusion Criteria

- Lidocaine sensitivity

- Bleeding disorder

- Pregnancy

- Medical conditions which would impair hepatic blood flow: congestive heart failure,
liver dysfunction, peripheral vascular disease.

- Subjects who are unable to understand the protocol or to give informed consent

- Subjects with mental illness

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

The Number of Subjects With Detectable Serum Lidocaine Concentrations (<0.1 ug/mL) at Each Blood Draw.

Outcome Time Frame:

6 hours

Safety Issue:

No

Principal Investigator

Murad Alam, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Northwestern University

Authority:

United States: Institutional Review Board

Study ID:

MA-stu1404

NCT ID:

NCT00793169

Start Date:

September 2007

Completion Date:

July 2008

Related Keywords:

  • Basal Cell Carcinoma
  • Squamous Cell Carcinoma
  • squamous cell carcinoma of the head or neck
  • Carcinoma
  • Carcinoma, Basal Cell
  • Carcinoma, Squamous Cell

Name

Location

Northwestern UniversityChicago, Illinois  60611